These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 25296596)

  • 1. Non-metastatic Ewing's sarcoma family of tumors of bone in adolescents and adults: prognostic factors and clinical outcome-single institution results.
    Oksüz DC; Tural D; Dincbas FÖ; Dervisoglu S; Turna H; Hiz M; Kantarci F; Ceylaner B; Koca S; Mandel NM
    Tumori; 2014; 100(4):452-8. PubMed ID: 25296596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraskeletal Ewing's sarcoma family of tumors in adults: prognostic factors and clinical outcome.
    Tural D; Molinas Mandel N; Dervisoglu S; Oner Dincbas F; Koca S; Colpan Oksuz D; Kantarci F; Turna H; Selcukbiricik F; Hiz M
    Jpn J Clin Oncol; 2012 May; 42(5):420-6. PubMed ID: 22416252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which Factors Are Associated with Local Control and Survival of Patients with Localized Pelvic Ewing's Sarcoma? A Retrospective Analysis of Data from the Euro-EWING99 Trial.
    Andreou D; Ranft A; Gosheger G; Timmermann B; Ladenstein R; Hartmann W; Bauer S; Baumhoer D; van den Berg H; Dijkstra PDS; Dürr HR; Gelderblom H; Hardes J; Hjorth L; Kreyer J; Kruseova J; Leithner A; Scobioala S; Streitbürger A; Tunn PU; Wardelmann E; Windhager R; Jürgens H; Dirksen U;
    Clin Orthop Relat Res; 2020 Feb; 478(2):290-302. PubMed ID: 31580267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting multiagent chemotherapy in adult high-risk Ewing's sarcoma of bone.
    Ataergin S; Ozet A; Solchaga L; Turan M; Beyzadeoglu M; Oysul K; Arpaci F; Komurcu S; Surenkok S; Ozturk M
    Med Oncol; 2009; 26(3):276-86. PubMed ID: 18989798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology.
    Arpaci E; Yetisyigit T; Seker M; Uncu D; Uyeturk U; Oksuzoglu B; Demirci U; Coskun U; Kucukoner M; Isıkdogan A; Inanc M; Alkis N; Ozkan M
    Med Oncol; 2013 Mar; 30(1):469. PubMed ID: 23345116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors.
    Dramis A; Grimer RJ; Malizos K; Tillman RM; Jeys L; Carter LR
    Acta Orthop Belg; 2016 Aug; 82(2):216-221. PubMed ID: 27682283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and survival of 92 cases of Ewing's sarcoma family of tumor initially treated with multidisciplinary therapy].
    Peng RJ; Sun XF; Xiang XJ; Zhen ZJ; Ling JY; Tong GL; Xia Y; Xu GC; Jiang WQ
    Ai Zheng; 2009 Dec; 28(12):1304-9. PubMed ID: 19958626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ewing's sarcoma and primitive neuroectodermal tumor of hand and forearm. Experience of the Cooperative Ewing's Sarcoma Study Group.
    Daecke W; Ahrens S; Juergens H; Martini AK; Ewerbeck V; Kotz R; Winkelmann W; Bernd L
    J Cancer Res Clin Oncol; 2005 Apr; 131(4):219-25. PubMed ID: 15614525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of prognostic factors of pediatric-type sarcomas in adult patients.
    Ahn HK; Uhm JE; Lee J; Lim DH; Seo SW; Sung KS; Lee SJ; Lee DJ; Baek KK; Kim WS; Park JO
    Oncology; 2011; 80(1-2):21-8. PubMed ID: 21606660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV.
    Nilbert M; Saeter G; Elomaa I; Monge OR; Wiebe T; Alvegård TA
    Acta Oncol; 1998; 37(4):375-8. PubMed ID: 9743460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up and prognostic factors in Ewing's sarcoma. A multivariate analysis of 116 patients from a single institution.
    Aparicio J; Munárriz B; Pastor M; Vera FJ; Castel V; Aparisi F; Montalar J; Badal MD; Gómez-Codina J; Herranz C
    Oncology; 1998; 55(1):20-6. PubMed ID: 9428371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome.
    Baldini EH; Demetri GD; Fletcher CD; Foran J; Marcus KC; Singer S
    Ann Surg; 1999 Jul; 230(1):79-86. PubMed ID: 10400040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose chemotherapy and autologous peripheral blood stem-cell transfusion after conventional chemotherapy for patients with high-risk Ewing's tumors.
    Tanaka K; Matsunobu T; Sakamoto A; Matsuda S; Iwamoto Y
    J Orthop Sci; 2002; 7(4):477-82. PubMed ID: 12181663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant chemotherapy for peripheral malignant neuroectodermal tumor of bone: recent experience at the istituto rizzoli.
    Bacci G; Ferrari S; Bertoni F; Donati D; Bacchini P; Longhi A; Brach Del Prever A; Forni C; Rimondini S
    J Clin Oncol; 2000 Feb; 18(4):885-92. PubMed ID: 10673532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years.
    Kharod SM; Spiguel AR; Lagmay JP; Jones C; Morris CG; Gibbs CP; Zlotecki RA
    Am J Clin Oncol; 2019 May; 42(5):421-425. PubMed ID: 30883389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk analysis factors for local recurrence in Ewing's sarcoma: when should adjuvant radiotherapy be administered?
    Albergo JI; Gaston CLL; Parry MC; Laitinen MK; Jeys LM; Tillman RM; Abudu AT; Grimer RJ
    Bone Joint J; 2018 Feb; 100-B(2):247-255. PubMed ID: 29437069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival of patients with Ewing's sarcoma in Yazd-Iran.
    Akhavan A; Binesh F; Shamshiri H; Ghanadi F
    Asian Pac J Cancer Prev; 2014; 15(12):4861-4. PubMed ID: 24998554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapy and survival after recurrence of Ewing's tumors: the Rizzoli experience in 195 patients treated with adjuvant and neoadjuvant chemotherapy from 1979 to 1997.
    Bacci G; Ferrari S; Longhi A; Donati D; De Paolis M; Forni C; Versari M; Setola E; Briccoli A; Barbieri E
    Ann Oncol; 2003 Nov; 14(11):1654-9. PubMed ID: 14581274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A SEER-based nomogram accurately predicts prognosis in Ewing's sarcoma.
    Zhan H; Mo F; Zhu M; Xu X; Zhang B; Liu H; Dai M
    Sci Rep; 2021 Nov; 11(1):22723. PubMed ID: 34811459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.